NASDAQ
Better Therapeutics, Inc. (BTTX) has a current ratio of 1.37x as of Monday, May 25, 2026. This represents a 66.79% decrease compared to its 12-month average of 4.12x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.